FTC sues significant pharmacy benefit supervisors above insulin rates The agency introduced action versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the list cost of existence-preserving insulin medication. This strategy aligns with Those people attempts, the ONC explained. The market is tackling https://elliottdaasn.blogoxo.com/30763182/healthcare-news-secrets